Raymond James analyst Brian Peterson lowered the firm’s price target on Veeva to $200 from $215 and keeps an Outperform rating on the shares. Peterson sees a below-consensus outlook for FY23, though none of the growth/margin headwinds are structural in nature, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VEEV:
- Veeva price target lowered to $225 from $250 at Oppenheimer
- Veeva issues statement in support of proposed FTC ban on non-competes
- Veeva price target lowered to $204 from $220 at Piper Sandler
- Barclays upgrades Veeva to Overweight as defensive pick
- Veeva upgraded to Overweight from Equal Weight at Barclays